UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000019787
Receipt number	R000022855
Scientific Title	Phase 2 clinical study of neoadjuvant chemotherapy for HER2-negative primary breast cancer patients using dose dense nab-paclitaxel followed by dose dense Epirubicin and cyclophosphamide
Date of disclosure of the study information	2016/01/01
Last modified on	2015/11/14 13:38:37

---